GCTK GlucoTrack, Inc.
Healthcare$0.59+18.92%ClosedMarket Cap: $337,409
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.96
P/S
0.00
EV/EBITDA
0.22
DCF Value
$6.81
FCF Yield
-5792.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-582.0%
ROA
-387.7%
ROIC
1378.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-4.2M | $-4.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.5M | $-3.6M | $— | — |
| FY null | $0.00 | NaN% | $-16.1M | $-19.4M | $— | — |
| Q3 null | $0.00 | NaN% | $4.3M | $-4.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.8M | $-4.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.5M | $-6.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-25.2M | $-10.1M | $— | — |
| FY null | $0.00 | NaN% | $-14.5M | $-22.6M | $— | — |
| Q3 null | $0.00 | NaN% | $3.3M | $-5.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.5M | $-4.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-3.0M | $-2.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-11.8M | $-2.4M | $-9.05 | — |